InVivo Animal Nutrition and Health announces today the acquisition of Daavision, an international Dutch company specialised in the production and marketing of specialty additives for animal nutrition, mainly based on organic fatty acids.
A strategic acquisition which complements the current specialty additives offer in a growing market.
InVivo Animal Nutrition and Health is a worldwide leader in its sector with a turnover of € 1.5 billion.
The company operates in 28 countries and announces today the acquisition of Daavision, an
international Dutch company specialised in the production and marketing of specialty additives for
animal nutrition, mainly based on organic fatty acids.
An acquisition that leverages the innovation and internationalization potential of the company
Founded in 2004, Daavision manufactures its products in the Netherlands and markets them in more than 30 countries. The company has “a state of the art” production site (2008) located in Oss in the Netherlands and benefits from an innovative and experienced staff. In addition, Daavision is very well known for its know-how in farm animals feeding and has been able to develop tailor made solutions to answer to any breeding environmental conditions. This unique ability lies on the strong innovation DNA of the company which has for instance been the first to develop the use of lauric acid as a powerful antibacterial in the agri-food industry.
The clear ambition to build a global leader in the specialty additives business
The integration of Daavision within the specialty additives business line of InVivo NSA will give the company the opportunity to broaden its range of services, to benefit from additional research capabilities and financial means and to improve its distribution network in Europe and Russia.
Ejal Heijman,CEO of Daavision, indicates that : « joining InVivo NSA Group will help Daavision to accelerate its development and to rely on the global network and research capabilities of the Group”. Buis Ebbinge, shareholder, adds: « the combination of the commercial means of InVivo NSA and Daavision at global level will play a key role in our future growth “.
Hubert de Roquefeuil, CEO of InVivo NSA concludes: « the acquisition of Daavision confirms our strong ambition to build a global leader in the specialty additives business. It also illustrates our willingness to complement our range of specialty additives, both in terms of products and geographies. Finally, it embodies our strategy: continue to target investments in sectors, countries and species with strong growth potential. That strategy will allow us to progressively build an ever more balanced and resilient business model ».
———————————————————————————————————————————————–
For further information, please contact:
Matthieu Leroy Emilie Servan-Besnard
Director of Projects, Information Systems Communication Manager – InVivo NSA
and Communication – InVivo NSA Phone: +33 (0)2 97 48 55 04
mleroy@invivo-nsa.com ebesnard@invivo-nsa.com
About InVivo NSA: InVivo Animal Nutrition and Health has five main activities (complete feed, firm services, additives and ingredients, analysis laboratories, and animal health). It employs 7,050 people on 73 production sites in 28 countries. InVivo Animal Nutrition and Health generates a turnover of 1.5 billion euros. www.invivo-nsa.com
